Education and Training

DERM US and EU Validation Study

This study aims establish the effectiveness of Image Analysing Algorithm (DERM) to identify melanoma, Squamous Cell Carcinoma (SCC) and Basal Cell Carcinoma (BCC) when used to analyse dermoscopic images of skin lesions within the US and European population.

Stanford is currently not accepting patients for this trial.

Intervention(s):

  • device: Deep Ensemble for the Recognition of Malignancy (DERM)

Eligibility


Inclusion Criteria:

   - Willing and able to give informed consent for participation in the study,

   - Male or Female, aged 18 years or above,

   - Have at least one suitable skin lesion that will be biopsied due to a suspicion of
   skin cancer,

To be suitable for inclusion, a skin lesion must NOT have ANY of the following limitations:

located on an anatomical site of different skin structure: palms of hands or soles of feet
(acral lesion), mucosal surfaces (lips and eyes) or under nail (ungal lesion), a diameter
greater than the diameter of the dermoscopic lenses, located on an anatomical site
unsuitable for photographing, including on surface of genitals and hair-bearing areas, has
been previously biopsied, excised, treated or otherwise traumatised, located in an area of
visible scarring or tattooing.

- In the Investigator's opinion, able and willing to comply with all study requirements.

Exclusion Criteria:

   - Any other significant disease or disorder which, in the opinion of the Investigator,
   may either put the participant at risk because of participation in the study, or may
   influence the result of the study, or the participant's ability to participate in the
   study.

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study

All

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Niki Saruwatari
+1 650-723-4309
Not Recruiting